87 related articles for article (PubMed ID: 10348260)
1. Use of amifostine in the treatment of recurrent solid tumours in children.
Sidi V; Arsos G; Papakonstantinou E; Hatzipantelis E; Fragandrea I; Gombakis N; Koliouskas E
Hippokratia; 2007 Jan; 11(1):25-9. PubMed ID: 19582173
[TBL] [Abstract][Full Text] [Related]
2. Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer.
Shibata K; Nakatsumi Y; Kasahara K; Bando T; Fujimura M; Matsuda T
J Cancer Res Clin Oncol; 1996; 122(7):437-42. PubMed ID: 8690756
[TBL] [Abstract][Full Text] [Related]
3. Managing thrombocytopenia associated with cancer chemotherapy.
Kuter DJ
Oncology (Williston Park); 2015 Apr; 29(4):282-94. PubMed ID: 25952492
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae.
Apicella MA; Ketterer M; Lee FK; Zhou D; Rice PA; Blake MS
J Infect Dis; 1996 Mar; 173(3):636-46. PubMed ID: 8627027
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers.
Markman M; Markman J; Webster K; Zanotti K; Kulp B; Peterson G; Belinson J
J Cancer Res Clin Oncol; 2004 Dec; 130(12):741-4. PubMed ID: 15338296
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets.
Josefsson EC; James C; Henley KJ; Debrincat MA; Rogers KL; Dowling MR; White MJ; Kruse EA; Lane RM; Ellis S; Nurden P; Mason KD; O'Reilly LA; Roberts AW; Metcalf D; Huang DC; Kile BT
J Exp Med; 2011 Sep; 208(10):2017-31. PubMed ID: 21911424
[TBL] [Abstract][Full Text] [Related]
7. Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues.
Asiri YA
Oxid Med Cell Longev; 2010; 3(5):308-16. PubMed ID: 21150336
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
Hartmann JT; von Vangerow A; Fels LM; Knop S; Stolte H; Kanz L; Bokemeyer C
Br J Cancer; 2001 Feb; 84(3):313-20. PubMed ID: 11161394
[TBL] [Abstract][Full Text] [Related]
9. Protection by amifostine of cyclophosphamide-induced myelosuppression.
Alberts DS
Semin Oncol; 1999 Apr; 26(2 Suppl 7):37-40. PubMed ID: 10348259
[TBL] [Abstract][Full Text] [Related]
10. Future development of amifostine as a radioprotectant.
Werner-Wasik M
Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
[TBL] [Abstract][Full Text] [Related]
11. Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostine.
Budd GT; Ganapathi R; Wood L; Snyder J; McLain D; Bukowski RM
Semin Oncol; 1999 Apr; 26(2 Suppl 7):41-50. PubMed ID: 10348260
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.
Selvaggi G; Belani CP
Semin Oncol; 1999 Apr; 26(2 Suppl 7):51-60. PubMed ID: 10348261
[TBL] [Abstract][Full Text] [Related]
13. Neurologic protection by amifostine.
DiPaola RS; Schuchter L
Semin Oncol; 1999 Apr; 26(2 Suppl 7):82-8. PubMed ID: 10348265
[TBL] [Abstract][Full Text] [Related]
14. Amifostine and chemotherapy-related thrombocytopenia.
Budd GT
Semin Oncol; 1996 Aug; 23(4 Suppl 8):49-52. PubMed ID: 8783667
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
